±ÝÀ¶»ê¾÷ȯ°æ°ú ±¹³» ±ÝÀ¯È¸»çÀÇ ±Û·Î¹ú Àü·« À¯Çü, Global IT ¿ª·®°ú ¼öÁØ
David Turberfield
Managing Director & Partner, ERM Korea Ltd.
¾à·Â
David Turberfield has seventeen years¡¯ experience providing practical and strategic solutions to corporate and operational management for the private sector and Government throughout Asia.
David has an MSc in Environmental Impact Assessment and extensive project experience in Environmental Management Systems, Environmental Assessment and Environmental Audit.
Mr Turberfield has lived and worked in the Asia Pacific Region for over thirteen years having been based in Korea, Malaysia, Thailand and Singapore and has worked on projects in Australia,
Azerbaijan, Brunei, Ethiopia, France, Georgia, China, Germany, India, Indonesia, Japan, Philippines, Portugal, Taiwan, Vietnam, USA and the UK.
Professionally, Mr Turberfield is a business developer and manager having grown and managed teams of up to 25 consultants and managed a number of business start ups and a turn around in Malaysia, Bangkok, London and Singapore. In terms of clients, he has worked in a broad range
of sectors including the following:
· General manufacturing - key clients including Nike, Meritor, Syngenta, Umicore, MEMC.
· Pharmaceutical and consumer products - key clients including Johnson & Johnson, Baxter, GSK, Pfizer, Unilever.
· Finance - key clients including ABN Amro, Standard Bank, Standard Chartered Bank, Mitsuho, SMBC, KExim, Saratoga Capital.
· Utilities - key clients including Intergen, Scottish Power, AES, Tuas Power, Power Seraya, Senoko Power.
· Oil and gas - key clients including Shell, bp, ExxonMobil, Chevron, Amerada Hess.
· Chemical and petrochemical - key clients including Invista, Soxal, Linde, SI Group, Huntsman, Mitsubishi, Mitsui.
As Managing Director of ERM¡¯s office in Korea, and previously Managing Director of ERM¡¯s office in Singapore, Mr Turberfield has responsibility and accountability for financial performance,
development strategy and implementation, recruitment and staff development, technical project management and delivery and development of client relationships.
¼¼¼Ç¸í
Sustainable Business Strategy: Delivering Business Value
¼¼¼Ç ÁÖÁ¦
In this session Mr. Turberfield will present some of the strategies being employed by the private sector aimed at achieving sustainable development. The presentation include case studies on low carbon inventory development, emission reduction strategies and sustainability strategy/ master planning.
¼¼¼Ç ¿ä¾à
Corporations are asking themselves what does sustainability mean for our business? How can we use sustainability to create additional business value? Do we have a handle on specific opportunities, the business value we could deliver and what to prioritize? How do we integrate
sustainability into our core business strategy, culture, and decision-making processes? Companies are developing a variety of strategic approaches to address such questions but a universal finding from around the world is that a good sustainable strategy is good for the company, good for employees, good for stakeholders and good business.
Michael Hadjisavas, PhD
Vice President Corporate Development, Advanced Genomics,
Life Technologies Corporation
¾à·Â
Michael Hadjisavas, Ph.D., currently serves as VP Corporate Development for Advanced Genomics
at Life Technologies Corporation. Dr. Hadjisavas is a life science executive professional with over
15 years of corporate experience in product development, commercialization, business
management and corporate development. He joined Invitrogen prior to its merger with Applied
Biosystems, Inc., in March 2008. In his role, he is responsible for analysis and formulation of
corporate strategies for advanced genomics technologies with a current emphasis on strategies
for informatics and IT for genomics. Prior experience includes multiple leadership positions at
Applied Biosystems, Sigma-Aldrich Corporation and Genosys Biotechnologies. Dr. Hadjisavas
holds a science degree with majors in microbiology, immunology and biochemistry with a PhD
in molecular and cellular immunology from the University of Adelaide in Australia.
¼¼¼Ç¸í
Personalized Theraphy by Life Science and IT
¼¼¼Ç ¿ä¾à
The cost of whole human genome sequencing has been significantly reduced over the last 20 years and indications suggest that cost will continue to fall below $1000 over the next few years. This is driven primarily by the development and deployment of compelling technological advancements in sequencing that have emerged over the last five years. These technologies are creating significant challenges for commercial entities, medical professionals and scientist as they begin to contemplate the opportunities that are enabled by these technologies. This presentation will address challenges in three key areas:
IT and informatics challenges for managing and analyzing genomics data.
Adoption of genomics information for clinical research.
Commercialization models for genomic-based medicine.
The challenges will be discussed in each these cases from the perspective of a commercial entity that is seeking to augment research and disease management with whole genome sequencing.
Mark Tansley (Director, Capgemini Australia)
¼¼¼Ç¸í
Creating IT synergy through enterprise application and system integration
¼¼¼Ç ÁÖÁ¦
This session will look at various circumstances under which enterprise application system integration is necessary, such as in case of M/A. It will lead to careful system design and implementation to cover various cross-sector applications, such as CRM, Product Management,
DW, Management Support, etc. Various case studies and trends in such integration effort, specially in financial sector, will be looked at, in addition to providing types, extent, and impact of such integration projects.
¼¼¼Ç ¿ä¾à
Companies are looking at ways to integrate various enterprise applications, for example banking, securities, capital, and asset management systems in financial sector, to create synergy under various instances, such as M/A. As a result, this will impact different related target systems,
including CRM, EIS, DW, Channel/Product management, etc. In order to plan for successful integration to create IT synergy, it is necessary to study various previous integration project types and lessons learned. This session will examine current trends
and environment under which such integration happens, followed by example project cases with goal, progress, benefit, conceptual image. Also, helpful consideration points from these project experiences, with typical scope and impact of such effort. After it¡¯s implementation, it¡¯s
implications to enterprise¡¯s performance analysis factors such as KPI and reporting generation will be looked at.
Key note
IT Integration, Financial Industry, Synergy, Enterprise Application, M/A